Skip to main content

Supplementary Table S3 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration

Publication ,  Other
Ludwig, AL; McKay, ZP; Carter, GP; Katz, MA; Howell, G; Jain, V; Arvai, S; Dittmer, DP; Bigner, DD; Ashley, DM; Shoaf, ML; Desjardins, A ...
February 3, 2026

<p>Supplementary Table S3. Top-20 differentially expressed genes in tumor-infiltrating T cell subsets (extended data relating to Figure 5D).</p>

Duke Scholars

DOI

Publication Date

February 3, 2026
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ludwig, A. L., McKay, Z. P., Carter, G. P., Katz, M. A., Howell, G., Jain, V., … Gromeier, M. (2026). Supplementary Table S3 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. https://doi.org/10.1158/2326-6066.31239107
Ludwig, Andrea L., Zachary P. McKay, Griffin P. Carter, Mark A. Katz, Georgia Howell, Vaibhav Jain, Stephanie Arvai, et al. “Supplementary Table S3 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration,” February 3, 2026. https://doi.org/10.1158/2326-6066.31239107.
Ludwig AL, McKay ZP, Carter GP, Katz MA, Howell G, Jain V, Arvai S, Dittmer DP, Bigner DD, Ashley DM, Shoaf ML, Desjardins A, Gregory SG, Brown MC, Gromeier M. Supplementary Table S3 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. 2026.

DOI

Publication Date

February 3, 2026